Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • AtriCure's Interest & Investment Income fell 905.54% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 189.65%. This contributed to the annual value of $4.4 million for FY2024, which is 1693.04% up from last year.
  • Per AtriCure's latest filing, its Interest & Investment Income stood at $1.2 million for Q3 2025, which was down 905.54% from $941000.0 recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Interest & Investment Income peaked at $1.4 million during Q4 2022, and registered a low of $76000.0 during Q2 2022.
  • For the 5-year period, AtriCure's Interest & Investment Income averaged around $728105.3, with its median value being $941000.0 (2025).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 6691.36% in 2021, then skyrocketed by 117857.14% in 2022.
  • Quarter analysis of 5 years shows AtriCure's Interest & Investment Income stood at $112000.0 in 2021, then surged by 1178.57% to $1.4 million in 2022, then dropped by 27.3% to $1.0 million in 2023, then rose by 15.66% to $1.2 million in 2024, then fell by 3.24% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $941000.0 for Q2 2025, and $1.0 million during Q1 2025.